Wikipedia

Snake venom

Snake venomis a highly toxicsaliva[1]containingzootoxinsthat facilitates in the immobilization and digestion ofprey.This also provides defense against threats. Snake venom is usually injected by uniquefangsduring abite,though some species are also able to spitvenom.[2]

Vipera berus- Venom delivery apparatus

Thevenom glandsthat secrete zootoxins are a modification of theparotid salivary glandsfound in othervertebratesand are usually located on each side of the head, below and behind the eye, and enclosed in a muscular sheath. The venom is stored in large glands calledalveolibefore being conveyed by a duct to the base of channeled or tubular fangs through which it's ejected.[3][4]

Venom contains more than 20 different compounds, which are mostly proteins andpolypeptides.[3][5]The complex mixture of proteins, enzymes, and various other substances has toxic and lethal properties.[2]Venom serves to immobilize prey.[6]Enzymesin venom play an important role in the digestion of prey,[4]and various other substances are responsible for important but non-lethal biological effects.[2]Some of the proteins in snake venom have very specific effects on various biological functions, including blood coagulation, blood pressure regulation, and transmission of nerve or muscle impulses. These venoms have been studied and developed for use as pharmacological or diagnostic tools, and even drugs.[2][5]

Chemistry

edit

Proteinsconstitute 90-95% of venom's dry weight and are responsible for almost all of its biological effects.[5][7]The hundreds, even thousands, of proteins found in venom include toxins,neurotoxinsin particular, as well as nontoxic proteins (which also have pharmacological properties), and many enzymes, especiallyhydrolyticones.[2]Enzymes (molecular weight13-150 KDa) make up 80-90% ofviperidand 25-70% ofelapidvenoms, including digestivehydrolases,L-amino-acid oxidase,phospholipases,thrombin-like pro-coagulant, andkallikrein-likeserine proteasesandmetalloproteinases(hemorrhagins), which damage vascularendothelium.Polypeptide toxins (molecular weight 5-10 KDa) includecytotoxins,cardiotoxins,andpostsynapticneurotoxins (such asα-bungarotoxinandα-Cobratoxin), which bind toacetylcholine receptorsat neuromuscular junctions. Compounds with low molecular weight (up to 1.5 KDa) include metals, peptides, lipids,nucleosides,carbohydrates, amines, andoligopeptides,which inhibitangiotensin-converting enzyme(ACE) and potentiate bradykinin (BPP). Inter- and intra-species variation in venom chemical composition is geographical and ontogenic.[3]Phosphodiesterasesinterfere with the prey's cardiac system, mainly to lower theblood pressure.Phospholipase A2causeshemolysisby lysing thephospholipidcell membranesofred blood cells.[8]Amino acidoxidasesandproteasesare used for digestion. Amino acid oxidase also triggers some other enzymes and is responsible for the yellow colour of the venom of some species.Hyaluronidaseincreases tissue permeability to accelerate the absorption of other enzymes into tissues. Some snake venoms carryfasciculins,like themambas(Dendroaspis), which inhibitcholinesteraseto make the prey lose muscle control.[9]

Main enzymes of snake venom[2][5][10]
Type Name Origin
Oxidoreductases lactate dehydrogenase Elapidae
L-amino-acid oxidase All species
Catalase All species
Transferases Alanine amino transferase
Hydrolases Phospholipase A2 All species
Lysophospholipase Elapidae, Viperidae
Acetylcholinesterase Elapidae
Alkaline phosphatase Bothrops atrox
Acid phosphatase Deinagkistrodon acutus
5'-nucleotidase All species
Phosphodiesterase All species
Deoxyribonuclease All species
Ribonuclease 1 All species
Adenosine triphosphatase All species
Amylase All species
Hyaluronidase All species
NAD-Nucleotidase All species
Kininogenase Viperidae
Factor Xactivator Viperidae, Crotalinae
Heparinase Crotalinae
α-Fibrinogenase Viperidae, Crotalinae
β-Fibrinogenase Viperidae, Crotalinae
α-β-Fibrinogenase Bitis gabonica
Fibrinolytic enzyme Crotalinae
Prothrombin activator Crotalinae
Collagenase Viperidae
Elastase Viperidae
Lyases Glucosaminate ammonia-lyase

Snake toxins vary greatly in their functions. The two broad classes of toxins found in snake venoms areneurotoxins(mostly found in elapids) andhemotoxins(mostly found in viperids). However, exceptions occur – the venom of theblack-necked spitting cobra(Naja nigricollis), an elapid, consists mainly ofcytotoxins,while that of theMojave rattlesnake(Crotalus scutulatus), a viperid, is primarily neurotoxic. Both elapids and viperids may carry numerous other types of toxins.

α-neurotoxins α-Bungarotoxin,α-toxin,erabutoxin,cobratoxin
β-neurotoxins (PLA2) β-Bungarotoxin,Notexin,ammodytoxin,crotoxin,taipoxin
κ-neurotoxins Kappa-bungarotoxin
Dendrotoxins (Kunitz) Dendrotoxin,toxins I and K; possiblyβ-Bungarotoxinchain B
Cardiotoxins Naja nigricollisy-toxin,cardiotoxin III(aka cytotoxins)
Myotoxins Myotoxin-a,crotamine
Sarafotoxins Sarafotoxinsa, b, and c
Hemorrhagins (metalloprotease) Mucrolysin,Atrolysins,Acutolysins,etc.[11]
Hemotoxins (serine protease) Venombin A

Toxins

edit

Neurotoxins

edit
Structure of a typicalchemical synapse

The beginning of a new neural impulse goes as follows:

  1. An exchange of ions (charged atoms) across the nerve cell membrane sends a depolarizing current towards the end of the nerve cell (cell terminus).
  2. When the depolarizing current arrives at the nerve cell terminus, the neurotransmitteracetylcholine(ACh), which is held invesicles,is released into the space between the two nerves (synapse). It moves across the synapse to the postsynaptic receptors.
  3. ACh binds to the receptors and transfers the signal to the target cell, and after a short time, it's destroyed by acetylcholinesterase.

Fasciculins

edit
These toxins attackcholinergicneurons (those that use ACh as a transmitter) by destroying acetylcholinesterase (AChE). ACh, therefore, cannot be broken down and stays in the receptor. This causestetany(involuntary muscle contraction), which can lead to death. The toxins have been called fasciculins since after injection intomice,they cause severe, generalized and long-lasting (5-7 h)fasciculations(rapid muscle contractions).
Snake example: found mostly in the venom ofmambas(Dendroaspisspp.) and somerattlesnakes(Crotalusspp.)

Dendrotoxins

edit
Dendrotoxinsinhibit neurotransmissions by blocking the exchange of positive and negative ions across the neuronal membrane lead to no nerve impulse, thereby paralyzing the nerves.
Snake example:mambas

α-neurotoxins

edit
Alpha-neurotoxinsare a large group; over 100 postsynaptic neurotoxins having been identified and sequenced.[12]α-neurotoxins attack theNicotinic acetylcholine receptorsof cholinergic neurons. They mimic the shape of the acetylcholine molecule, and so fit into the receptors, where they block the ACh flow, leading to a feeling of numbness and paralysis.
Snake examples:king cobra(Ophiophagus hannah) (known as hannahtoxin containing α-neurotoxins),[13]sea snakes(Hydrophiinae) (known as erabutoxin),many-banded krait(Bungarus multicinctus) (known asα-bungarotoxin), andcobras(Najaspp.) (known ascobratoxin)

Cytotoxins

edit
Fully functional membrane
Destroyed membrane

Phospholipases

edit
Phospholipaseis an enzyme that transforms the phospholipid molecule into a lysophospholipid (soap) → the new molecule attracts and binds fat and ruptures cell membranes.Phospholipase A2is one specific type of phospholipases found in snake venom.
Snake example:Okinawan habu(Trimeresurus flavoviridis)

Cardiotoxins / Cytotoxins

edit
Cardiotoxinsare components that are specifically toxic to the heart. They bind to particular sites on the surface of muscle cells and cause depolarisation → the toxin prevents muscle contraction. These toxins may cause the heart to beat irregularly or stop beating, causing death. An example is thethree-fingeredcardiotoxin IIIfromChinese cobra,an example of the short three-fingered family (InterPro:IPR003572).
Snake example:mambas,and someNajaspecies

Hemotoxins

edit
Hemotoxinscause hemolysis, the destruction of red blood cells (erythrocytes), or induce blood coagulation (clotting, e.g.mucrocetin). A common family of hemotoxins includes snake venom metalloproteinases such asmucrolysin.[11][14]
Snake examples: mostvipersand manycobraspecies: The tropical rattlesnakeCrotalus durissusproducesconvulxin,a coagulant.[15]

Myotoxins

edit
Thetertiary structureof crotamine (PDB:1H5O​)

Myotoxinsare small, basicpeptidesfound inrattlesnake[16][17]andlizard(e.g.Mexican beaded lizard)[18]venoms. This involves a non-enzymatic mechanism that leads to severeskeletal musclenecrosis.These peptides act very quickly, causing instantaneousparalysisto preventpreyfrom escaping and eventually death due todiaphragmaticparalysis.

The first myotoxin to be identified and isolated wascrotamine,discovered in the 1950s byBrazilianscientistJosé Moura Gonçalvesfrom the venom of tropical South American rattlesnakeCrotalus durissus terrificus.Its biological actions,molecular structureandgeneresponsible for its synthesis were all elucidated in the last two decades.

Determining venom toxicity (LD50)

edit

Snake venom toxicity is assessed by a toxicological test called themedian lethal dose,lethal dose 50% (abbreviated as LD50), which determines the concentration of a toxin required to kill half the members of a tested population. The potency of wild snake venom varies considerably because of assorted influences such asbiophysical environment,physiological status,ecological variables,genetic variation (eitheradaptiveor incidental), and other molecular and ecological evolutionary factors.[citation needed]This is true even for members of one species. Such variation is smaller in captive populations in laboratory settings, though it cannot be eliminated. However, studies to determine snake venom potency must be designed to minimize variability.

Several techniques have been designed to this end. One approach is to use 0.1% bovine serum albumin (also known as "fraction V" inCohn process) as a diluent in determining LD50values. It results in more accurate and consistent LD50determinations than using 0.1% saline as a diluent. For example, fraction V produces about 95% purified albumin (dried crude venom). Saline as a diluent consistently produces widely varying LD50results for nearly all venomous snakes. It produces unpredictable variation in precipitate purity (35-60%).[19]Fraction V is structurally stable because it has seventeendisulfide bonds;it's unique in that it has the highest solubility and lowestisoelectric pointof major plasma proteins. This makes it the final fraction to be precipitated from its solution.Bovine serum albuminis located in fraction V. The precipitation of albumin is done by reducing the pH to 4.8, near the pH of the proteins, and maintaining the ethanol concentration at 40%, with a protein concentration of 1%. Thus, only 1% of the original plasma remains in the fifth fraction.[20]

When the ultimate goal of plasma processing is a purified plasma component forinjectionortransfusion,the plasma component must be highly pure. The first practical large-scale method of blood plasma fractionation was developed byEdwin J. CohnduringWorld War II.it's known as theCohn process(or Cohn method). This process is also known as cold ethanol fractionation, as it involves gradually increasing theconcentrationofethanolin thesolutionat 5 °C and 3 °C.[21]The Cohn Process exploits differences in plasma proteins properties, specifically, the highsolubilityand lowpIof albumin. As the ethanol concentration is increased in stages from 0 to 40%, the pH declines from neutral (pH ~ 7) to about 4.8, which is near the pI of albumin.[21]At each stage, proteins areprecipitated outof the solution and removed. The finalprecipitateis purified albumin. Several variations to this process exist, including an adapted method by Nitschmann and Kistler that uses fewer steps, and replacescentrifugationand bulk freezing withfiltrationand diafiltration.[21][22]Some newer methods of albumin purification add additional purification steps to the Cohn process and its variations. Chromatographic albumin processing emerged in the 1980s, however, it was not widely adopted until later due to the scarity of large-scalechromatographyequipment. Methods incorporating chromatography generally begin with cryo-depleted plasma undergoing buffer exchange via eitherdiafiltrationor buffer exchange chromatography, to prepare the plasma for followingion exchange chromatographysteps. After ion exchange, generally purification steps and buffer exchange occur.[21]

However, chromatographic methods began to be adopted in the 1980s.[citation needed]Developments were ongoing between when Cohn fractionation started emerge in 1946, and whenchromatographyemerged, in 1983. In 1962, the Kistler and Nistchmann process was created as a spin-off of the Cohn process. In the 1990s, the Zenalb and the CSL Albumex processes were created, which incorporated chromatography with variations. The general approach to using chromatography for plasma fractionation for albumin is: recovery of supernatant I, delipidation,anion exchange chromatography,cation exchange chromatography, and gel filtration chromatography. The recovered purified material is formulated with combinations of sodium octanoate and sodium N-acetyl tryptophanate and then subjected to viral inactivation procedures, including pasteurization at 60 °C. This is a more efficient alternative than the Cohn process because:

  • smooth automation and a relatively inexpensive plant was needed,
  • easier to sterilize equipment and maintain a good manufacturing environment
  • chromatographic processes are less damaging to the albumin protein
  • a more successful albumin result can be achieved.[citation needed]

Compared with the Cohn process, albumin purity increased from about 95% to 98% using chromatography, and the yield increased from about 65% to 85%. Small percentage increases make a difference in regard to sensitive measurements such as purity. The big drawback has to do with the economics. Although the method offered efficient, acquiring the necessary equipment was difficult. Large machinery is necessary, and for a long time, the lack of equipment availability limited its widespread use.[citation needed]

Evolution

edit
Main article:Evolution of snake venom

Venom evolved just once among allToxicoferaabout 170 million years ago, and then diversified into the huge venom diversity seen today.[23]The original toxicoferan venom was a very simple set of proteins that were assembled in a pair of glands. Subsequently, this set of proteins evolved independently in the various lineages of toxicoferans, includingSerpentes,Anguimorpha,andIguania.[24]Several snake lineages have since lost the ability to produce venom, often due to a change in diet or a change in predatory tactics.[23]In addition to this, venom strength and composition has changed due to changes in the prey of certain snake species. For example, the venom of the marbled sea snake (Aipysurus eydouxii) became significantly less toxic after the diet of this species changed from fish to strictly fish eggs.[23]The evolution of venom is thought to be responsible for the enormous expansion of snakes across the globe.[23][25]

The mechanism of evolution in most cases has beengene duplicationin tissues unrelated to the venom.[24]Pre-existing salivary proteins are the likely ancestors of most venom toxin genes.[26]Expression of the new protein in the venom gland followed duplication.[24]Then proceedednatural selectionforadaptive traitsfollowing the birth-and-death model, where duplication is followed by functional diversification, resulting in the creation of structurally related proteins that have slightly different functions.[23][24][27]The study of venom evolution has been a high priority for scientists in terms of scientific research, due to the medical relevance of snake venom, in terms of making antivenom and cancer research. Knowing more about the composition of venom and the ways it can potentially evolve is very beneficial. Three main factors that affect venom evolution have been closely studied: predators of the snake that are resistant to snake venom, prey that are in anevolutionary arms racewith snakes, and the specific diets that affect the intraspecific evolution of venom.[23][28]Venoms continue to evolve as specific toxins and are modified to target a specific prey, and toxins are found to vary according to diet in some species.[29][30]

Rapid venom evolution can also be explained by the arms race between venom-targeted molecules in resistant predators, such as theopossum,and the snake venom that targets the molecules. Scientists performed experiments on the opossums and found that multiple trials showed replacement to silent substitutions in the von Willebrand factor (vWf) gene that encodes for a venom-targeted hemostatic blood protein. These substitutions are thought to weaken the connection between vWf and a toxic snake venom ligand (botrocetin), which changes the net charge and hydrophobicity. These results are significant to the venom evolution because it's the first citation of rapid evolution in a venom-targeted molecule. This shows that an evolutionary arms race may be occurring in terms of defensive purposes. Alternative hypotheses suggest that venom evolution is due to trophic adaption, whereas these scientists believe, in this case, that selection would occur on traits that help with prey survival in terms of venom evolution instead of predation success. Several other predators of the pit viper (mongooses and hedgehogs) show the same type of relationship between snakes, which helps to support the hypothesis that venom has a very strong defensive role along with a trophic role. Which in turn supports the idea that predation on the snakes can be the arms race that produces snake venom evolution.[31]

Some of the various adaptations produced by this process include venom more toxic to specific prey in several lineages,[30][32][33]proteins that pre-digest prey,[34]as well as a method to track down prey after a bite.[35]Though venom function has evolved to be specific to prey class (e.g. particular coagulatory effects),[36]the evolution of broad toxicological effects (e.g.neurotoxicityor coagulotoxicity) does not appear to be broadly affected by prey type.[37]The presence ofdigestive enzymesin snake venom was once believed to be an adaptation to assist digestion. However, studies of thewestern diamondback rattlesnake(Crotalus atrox), a snake with highlyproteolyticvenom, show that venom has no impact on the time required for food to pass through thegut.[38]These various adaptations of venom have also led to considerable debate about the definition of venom and venomous snakes.[23]

Injection

edit

Vipers

edit

Invipers,which have the most highly developed venom-delivery apparatus, the venom gland is very large and is surrounded by themasseterortemporal muscle,which consists of two bands, the superior arising from behind the eye, the inferior extending from the gland to the mandible. A duct carries venom from the gland to the fang. In vipers and elapids, this groove is completely closed, forming a hypodermic needle-like tube. In other species, the grooves are not covered, or only partially covered. From the anterior extremity of the gland, the duct passes below the eye and above themaxillary bone,to the basal orifice of the venom fang, which is ensheathed in a thick fold ofmucous membrane.By means of the movable maxillary bone hinged to the prefrontal bone and connected with the transverse bone, which is pushed forward by muscles set in action by the opening of the mouth, the fang is erected and the venom discharged through the distal orifice. When the snake bites, the jaws close and the muscles surrounding the gland contract, causing venom to be ejected via the fangs.

Elapids

edit

In theproteroglyphouselapids,the fangs are tubular, but are short and do not possess the mobility seen in vipers.

Colubrids

edit

Opisthoglyphouscolubridshave enlarged, grooved teeth situated at the posterior extremity of themaxilla,where a small posterior portion of the upper labial or salivary gland produces venom.

Mechanics of biting

edit
European adder(Vipera berus), one fang with a small venom stain in glove, the other still in place

Several genera, includingAsian coral snakes(Calliophis),burrowing asps(Atractaspis), andnight adders(Causus), are remarkable for having exceptionally long venom glands, extending along each side of the body, in some cases extending posterially as far as the heart. Instead of the muscles of the temporal region serving to press out the venom into the duct, this action is performed by those of the side of the body.

Considerable variability in biting behavior is seen among snakes. When biting, viperid snakes often strike quickly, discharging venom as the fangs penetrate the skin, and then immediately release. Alternatively, as in the case of a feeding response, some viperids (e.g.Lachesis) bite and hold. Aproteroglyphoropisthoglyphmay close its jaws and bite or chew firmly for a considerable time.

Differences in fang length between the various venomous snakes are likely due to the evolution of different striking strategies.[39]Additionally, it has been shown that the fangs of different species of venomous snakes have different sizes and shapes depending on the biomechanical properties of the snake's prey.[40]

Mechanics of spitting

edit

Spitting cobrasof the generaNajaandHemachatus,when irritated or threatened, may eject streams or a spray of venom a distance of 1.2 metres (4 ft) to 2.4 metres (8 ft). These snakes' fangs have been modified for the purposes of spitting; inside the fangs, the channel makes a 90° bend to the lower front of the fang. Spitters may spit repeatedly and still be able to deliver a fatal bite.

Spitting is a defensive reaction only. The snakes tend to aim for the eyes of a perceived threat. A direct hit can cause temporary shock and blindness through severeinflammationof thecorneaandconjunctiva.Although usually no serious symptoms result if the venom is washed away immediately with plenty of water, blindness can become permanent if left untreated. Brief contact with the skin is not immediately dangerous, but open wounds may be vectors for envenomation.

Physiological effects

edit

The four distinct types of venom act on the body differently:

  • Proteolyticvenom dismantles the molecular surroundings, including at the site of the bite.
  • Hemotoxicvenom acts on the cardiovascular system, including the heart and blood.
  • Neurotoxicvenom acts on the nervous system, including the brain.
  • Cytotoxicvenom has a localized action at the site of the bite.

Proteroglyphous snakes

edit

The effect of the venom ofproteroglyphoussnakes (sea snakes,kraits,mambas,black snakes,tiger snakes,anddeath adders) is mainly on thenervous system,respiratoryparalysisbeing quickly produced by bringing the venom into contact with the central nervous mechanism that controls respiration; the pain and local swelling that follow a bite are not usually severe. The bite of all the proteroglyphous elapids, even of the smallest and gentlest, such as thecoral snakes,is, so far as known, deadly to humans. However, some mildly venomous elapids remain, such as the hooded snakes (Parasuta), bandy-bandies (Vermicella), etc.

Vipers

edit

Viper venom (Russell's viper,saw-scaled vipers,bushmasters,andrattlesnakes) acts more on the vascular system, bringing about coagulation of the blood and clotting of the pulmonary arteries; its action on the nervous system is not great, no individual group ofnerve-cellsappears to be picked out, and the effect upon respiration is not so direct; the influence upon the circulation explains the great depression, which is a symptom of viperine envenomation. The pain of the wound is severe and is rapidly followed by swelling and discoloration. The symptoms produced by the bite of the European vipers are thus described by Martin and Lamb:[41]

The bite is immediately followed by the local pain of a burning character; the limb soon swells and becomes discolored, and within one to three hours great prostration, accompanied byvomiting,and oftendiarrhea,sets in. Cold, clammy perspiration is usual. The pulse becomes extremely feeble, and slightdyspnoeaand restlessness may be seen. In severe cases, which occur mostly in children, the pulse may become imperceptible and the extremities cold; the patient may pass intocoma.In from twelve to twenty-four hours these severe constitutional symptoms usually pass off; but in the meantime, the swelling and discoloration have spread enormously. The limb becomes phlegmonous and occasionally suppurates. Within a few days recovery usually occurs somewhat suddenly, butdeathmay result from the severe depression or from the secondary effects ofsuppuration.That cases of death, in adults as well as in children, are not infrequent in some parts of the Continent is mentioned in the last chapter of this Introduction.

The Viperidae differ much among themselves in the toxicity of their venoms. Some, such as the Indian Russell's viper (Daboia russelli) and saw-scaled viper (E. carinatus); the American rattlesnakes (Crotalusspp.), bushmasters (Lachesisspp.), andlanceheads(Bothropsspp.); and theAfrican adders(Bitisspp.),night adders(Caususspp.), andhorned vipers(Cerastesspp.), cause fatal results unless a remedy is speedily applied. The bite of the larger European vipers may be very dangerous, and followed by fatal results, especially in children, at least in the hotter parts of the Continent; whilst the smallmeadow viper(Vipera ursinii), which hardly ever bites unless roughly handled, does not seem to be possessed of a very virulent venom, and although very common in some parts ofAustriaandHungary,is not known to have ever caused a serious accident.

Opisthoglyphous colubrids

edit

Biologists had long known that some snakes had rear fangs, 'inferior' venom injection mechanisms that might immobilize prey; although a few fatalities were on record, until 1957, the possibility that such snakes were deadly to humans seemed at most remote. The deaths of two prominent herpetologists,Robert MertensandKarl Schmidt,from African colubrid bites, changed that assessment, and recent events reveal that several other species of rear-fanged snakes have venoms that are potentially lethal to large vertebrates.

Boomslang(Dispholidus typus) andtwig snake(Thelotornisspp.) venoms are toxic to blood cells and thin the blood (hemotoxic, hemorrhagic). Early symptoms include headaches, nausea, diarrhea, lethargy, mental disorientation, bruising, and bleeding at the site and all body openings.Exsanguinationis the main cause of death from such a bite.

The boomslang's venom is the most potent of all rear-fanged snakes in the world based on LD50.Although its venom may be more potent than some vipers and elapids, it causes fewer fatalities owing to various factors (for example, the fangs' effectiveness is not high compared with many other snakes, the venom dose delivered is low, and boomslangs are generally less aggressive in comparison to other venomous snakes such as cobras and mambas). Symptoms of a bite from these snakes include nausea and internal bleeding, and one could die from abrain hemorrhageandrespiratory collapse.

Aglyphous snakes

edit

Experiments made with the secretion of theparotid glandofRhabdophisandZamenishave shown that evenaglyphoussnakes are not entirely devoid of venom, and point to the conclusion that the physiological difference between so-called harmless and venomous snakes is only one of degree, just as various steps exist in the transformation of an ordinary parotid gland into a venom gland or of a solid tooth into a tubular or grooved fang.

Use of snake venoms to treat disease

edit

Given that snake venom contains many biologically active ingredients, some may be useful to treat disease.[42]

For instance,phospholipases type A2(PLA2s) from the Tunisian vipersCerastes cerastesandMacrovipera lebetinahave been found to have antitumor activity.[43]Anticancer activity has been also reported for other compounds in snake venom.[44][45]PLA2s hydrolyze phospholipids, thus could act on bacterial cell surfaces, providing novel antimicrobial (antibiotic) activities.[46]

Theanalgesic(pain-killing) activity of many snake venom proteins has been long known.[47][48]The main challenge, however, is how to deliver protein to the nerve cells: proteins usually are not applicable as pills.

Immunity

edit

Among snakes

edit

The question whether individual snakes are immune to their own venom has not yet been definitively settled, though an example is known of a cobra that self-envenomated, resulting in a largeabscessrequiring surgical intervention, but showing none of the other effects that would have proven rapidly lethal in prey species or humans.[49]Furthermore, certain harmless species, such as theNorth Americancommon kingsnake(Lampropeltis getula) and theCentralandSouth Americanmussurana(Cleliaspp.), are proof against the venom of thecrotalines,which frequent the same districts, and which they are able to overpower and feed upon. Thechicken snake(Spilotes pullatus) is the enemy of thefer-de-lance(Bothrops caribbaeus) in St. Lucia, and in their encounters, the chicken snake is invariably the victor. Repeated experiments have shown the Europeangrass snake(Natrix natrix) not to be affected by the bite of theEuropean adder(Vipera berus) and theEuropean asp(Vipera aspis), this being due to the presence, in the blood of the harmless snake, of toxic principles secreted by the parotid and labial glands, and analogous to those of the venom of these vipers. Several North American species of rat snakes, as well as king snakes, have proven to be immune or highly resistant to the venom of rattlesnake species. The king cobra, which does prey on cobras, is said to be immune to their venom.

Among other animals

edit

Thehedgehog(Erinaceidae), themongoose(Herpestidae), thehoney badger(Mellivora capensis) and theopossumare known to be immune to a dose of snake venom.[citation needed]Recently, the honey badger and domestic pig were found to have convergently evolved amino-acid replacements in their nicotinic acetylcholine receptor, which are known to confer resistance to alpha-neurotoxins in hedgehogs.[50]Whether thepigmay be considered immune is still uncertain, though early studies show endogenous resistance in pigs tested against neurotoxins.[51]Though the pig'ssubcutaneouslayer of fat may protect it against snake venom, most venoms pass easily through vascular fat layers, making this unlikely to contribute to its ability to resist venoms. Thegarden dormouse(Eliomys quercinus) has recently been added to the list of animals refractory to viper venom. Some populations ofCalifornia ground squirrel(Otospermophilus beecheyi) are at least partially immune to rattlesnake venom as adults.

Among humans

edit

The acquisition of human immunity against snake venom is ancient (from around 60 CE,Psyllitribe). Research into development of vaccines that will lead to immunity is ongoing.Bill Haast,owner and director of the Miami Serpentarium, injected himself with snake venom during most of his adult life, in an effort to build up an immunity to a broad array of venomous snakes, in a practice known asmithridatism.Haast lived to age 100, and survived a reported 172 snake bites. He donated his blood to be used in treating snake-bite patients when a suitable antivenom was not available. More than 20 so-treated individuals recovered.[52][53][54]Amateur researcher Tim Friede also lets venomous snakes bite him in the hopes of a vaccine against snake venom being developed, and has survived over 160 bites from different species as of January 2016.[55]

Traditional treatments

edit
For approaches proven effective by modern medicine, seeSnakebite § Treatment.

TheWorld Health Organizationestimates that 80% of the world's population depends on traditional medicine for their primary health-care needs.[56]Methods of traditional treatments of snakebites, although of questionable efficacy and perhaps even harmful, are nonetheless relevant.

Plants used to treat snakebites in Trinidad and Tobago are made into tinctures with alcohol or olive oil and kept in rum flasks called snake bottles, which contain several different plants and/or insects. The plants used include the vine called monkey ladder (Bauhinia cumanensisorBauhinia excisa,Fabaceae), which is pounded and put on the bite. Alternatively, a tincture is made with a piece of the vine and kept in a snake bottle. Other plants used include mat root (Aristolochia rugosa), cat's claw (Pithecellobim unguis-cati), tobacco (Nicotiana tabacum), snake bush (Barleria lupulina), obie seed (Cola nitida), and wild gri gri root (Acrocomia aculeata). Some snake bottles also contain the caterpillars (Battus polydamas,Papilionidae) that eat tree leaves (Aristolochia trilobata). Emergency snake medicines are obtained by chewing a three-inch piece of the root of bois canôt (Cecropia peltata) and administering this chewed-root solution to the bitten subject (usually a hunting dog). This is a common native plant of Latin America and the Caribbean, which makes it appropriate as an emergency remedy. Another native plant used is mardi gras (Renealmia alpinia) (berries), which are crushed together with the juice of wild cane (Costus scaber) and given to the bitten. Quick fixes have included applying chewed tobacco from cigarettes, cigars, or pipes.[57]Making cuts around the puncture or sucking out the venom had been thought helpful in the past, but this course of treatment is now strongly discouraged, due to the risk of self-envenomation through knife cuts or cuts in the mouth (suction cups from snake bite kits can be used, but suctioning seldom provides any measurable benefit).[58][59]

Serotherapy

edit

Serotherapy usingantivenomis a common current treatment and has been described back in 1913.[note 1]Both adaptive immunity and serotherapy are specific to the type of snake; venom with identical physiological action do not cross-neutralize. Boulenger 1913 describes the following cases:

A European in Australia who had become immune to the venom of the deadly Australiantiger snake(Notechis scutatus), manipulating these snakes with impunity, and was under the impression that his immunity extended also to other species, when bitten by alowland copperhead(Austrelaps superbus), an allied elapine, died the following day.

InIndia,the serum prepared with the venom ofmonocled cobraNaja kaouthiahas been found to be without effect on the venom of two species ofkraits(Bungarus), Russell's viper (Daboia russelli), saw-scaled viper (Echis carinatus), andPope's pit viper(Trimeresurus popeiorum). Russell's viper serum is without effect on colubrine venoms, or those ofEchisandTrimeresurus.

InBrazil,serum prepared with the venom of lanceheads (Bothropsspp.) is without action on rattlesnake (Crotalusspp.) venom.

Antivenom snakebite treatment must be matched as the type of envenomation that has occurred. In the Americas, polyvalent antivenoms are available that are effective against the bites of most pit vipers.Crofabis the antivenom developed to treat the bite of North American pit vipers.[60]These are not effective againstcoral snakeenvenomation, which requires a specific antivenom to their neurotoxic venom. The situation is even more complex in countries such as India, with its rich mix of vipers (Viperidae) and highly neurotoxic cobras and kraits of the Elapidae.

Notes

edit
  1. ^This section is based on the 1913 bookThe Snakes of Europe,by G. A. Boulenger, which is now in thepublic domainin the United States (and possibly elsewhere) Because of its age, the text in this article should not necessarily be viewed as reflecting the current knowledge of snake venom

See also

edit

References

edit
  1. ^"Reptile Venom Research".Australian Reptile Park. Archived fromthe originalon 2 February 2010.Retrieved21 December2010.
  2. ^abcdefBauchot R (1994).Snakes: A Natural History.New York City, NY, USA: Sterling Publishing Co., Inc. pp.194–209.ISBN978-1-4027-3181-5.
  3. ^abcHalliday A, Kraig T, eds. (2002).Firefly Encyclopedia of Reptiles and Amphibians.Toronto, Canada: Firefly Books Ltd. pp.202–203.ISBN978-1-55297-613-5.
  4. ^abBottrall JL, Madaras F, Biven CD, Venning MG, Mirtschin PJ (September 2010)."Proteolytic activity of Elapid and Viperid Snake venoms and its implication to digestion".Journal of Venom Research.1(3): 18–28.PMC3086185.PMID21544178.
  5. ^abcdOliveira, Ana L.; Viegas, Matilde F.; da Silva, Saulo L.; Soares, Andreimar M.; Ramos, Maria J.; Fernandes, Pedro A. (July 2022)."The chemistry of snake venom and its medicinal potential".Nature Reviews Chemistry.6(7): 451–469.doi:10.1038/s41570-022-00393-7.ISSN2397-3358.PMC9185726.PMID35702592.
  6. ^Mattison C (2007).The New Encyclopedia of Snakes.New Jersey, USA (first published in the UK): Princeton University Press (Princeton and Oxford) first published in Blandford. p. 117.ISBN978-0-691-13295-2.
  7. ^Cardoso KC, Da Silva MJ, Costa GG, Torres TT, Del Bem LE, Vidal RO, et al. (October 2010)."A transcriptomic analysis of gene expression in the venom gland of the snake Bothrops alternatus (urutu)".BMC Genomics.11(1): 605.doi:10.1186/1471-2164-11-605.PMC3017861.PMID20977763.
  8. ^Condrea E, Devries A, Mager J (February 1964). "Hemolysis and splitting of human erythrocyte phospholipids by snake venoms".Biochimica et Biophysica Acta (BBA) - Specialized Section on Lipids and Related Subjects.84(1): 60–73.doi:10.1016/0926-6542(64)90101-5.PMID14124757.
  9. ^Rodríguez-Ithurralde D, Silveira R, Barbeito L, Dajas F (1983). "Fasciculin, a powerful anticholinesterase polypeptide from Dendroaspis angusticeps venom".Neurochemistry International.5(3): 267–74.doi:10.1016/0197-0186(83)90028-1.PMID20487949.S2CID8952817.
  10. ^Mackessy, Stephen P. (1 May 2021). Mackessy, Stephen P. (ed.).Handbook of Venoms and Toxins of Reptiles(2 ed.). Second edition. | Boca Raton: CRC Press, 2021.: CRC Press.doi:10.1201/9780429054204.ISBN978-0-429-05420-4.{{cite book}}:CS1 maint: location (link)
  11. ^ab"Keyword: Hemorrhagic toxin KW-1200".UniProt.Retrieved1 June2019.
  12. ^Hodgson WC, Wickramaratna JC (September 2002)."In vitro neuromuscular activity of snake venoms".Clinical and Experimental Pharmacology & Physiology.29(9): 807–14.doi:10.1046/j.1440-1681.2002.03740.x.PMID12165047.S2CID20158638.
  13. ^He YY, Lee WH, Zhang Y (September 2004). "Cloning and purification of alpha-neurotoxins from king cobra (Ophiophagus hannah)".Toxicon.44(3): 295–303.doi:10.1016/j.toxicon.2004.06.003.PMID15302536.
  14. ^Bernardoni JL, Sousa LF, Wermelinger LS, Lopes AS, Prezoto BC, Serrano SM, Zingali RB, Moura-da-Silva AM (14 October 2014)."Functional variability of snake venom metalloproteinases: adaptive advantages in targeting different prey and implications for human envenomation".PLOS ONE.9(10): e109651.Bibcode:2014PLoSO...9j9651B.doi:10.1371/journal.pone.0109651.PMC4196926.PMID25313513.
  15. ^Hermans C, Wittevrongel C, Thys C, Smethurst PA, Van Geet C, Freson K (August 2009)."A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder".Journal of Thrombosis and Haemostasis.7(8): 1356–63.doi:10.1111/j.1538-7836.2009.03520.x.PMID19552682.S2CID205728095.
  16. ^Griffin PR, Aird SD (November 1990)."A new small myotoxin from the venom of the prairie rattlesnake (Crotalus viridis viridis)".FEBS Letters.274(1–2): 43–47.doi:10.1016/0014-5793(90)81325-I.PMID2253781.S2CID45019479.
  17. ^Samejima Y, Aoki Y, Mebs D (1991). "Amino acid sequence of a myotoxin from venom of the eastern diamondback rattlesnake (Crotalus adamanteus)".Toxicon.29(4–5): 461–468.doi:10.1016/0041-0101(91)90020-r.PMID1862521.
  18. ^Whittington CM, Papenfuss AT, Bansal P, Torres AM, Wong ES, Deakin JE, et al. (June 2008)."Defensins and the convergent evolution of platypus and reptile venom genes".Genome Research.18(6): 986–994.doi:10.1101/gr.7149808.PMC2413166.PMID18463304.
  19. ^Broad AJ, Sutherland SK, Coulter AR (17 May 1979)."The lethality in mice of dangerous Australian and other snake venom"(PDF).Toxicon.17(6): 661–4.doi:10.1016/0041-0101(79)90245-9.PMID524395.
  20. ^Rosen FS (31 July 2003). "Edwin J. Cohn and the Development of Protein Chemistry".The New England Journal of Medicine.349(5): 511–512.doi:10.1056/NEJM200307313490522.
  21. ^abcdMatejtschuk P, Dash CH, Gascoigne EW (December 2000)."Production of human albumin solution: a continually developing colloid".British Journal of Anaesthesia.85(6): 887–95.doi:10.1093/bja/85.6.887.PMID11732525.
  22. ^Brodniewicz-Proba T (December 1991). "Human plasma fractionation and the impact of new technologies on the use and quality of plasma-derived products".Blood Reviews.5(4): 245–57.doi:10.1016/0268-960x(91)90016-6.PMID1782484.
  23. ^abcdefgFry BG, Casewell NR, Wüster W, Vidal N, Young B, Jackson TN (September 2012). "The structural and functional diversification of the Toxicofera reptile venom system".Toxicon.60(4): 434–48.doi:10.1016/j.toxicon.2012.02.013.PMID22446061.
  24. ^abcdCasewell NR, Wüster W, Vonk FJ, Harrison RA, Fry BG (April 2013). "Complex cocktails: the evolutionary novelty of venoms".Trends in Ecology & Evolution.28(4): 219–29.doi:10.1016/j.tree.2012.10.020.PMID23219381.
  25. ^Lomonte B, Fernández J, Sanz L, Angulo Y, Sasa M, Gutiérrez JM, Calvete JJ (June 2014). "Venomous snakes of Costa Rica: biological and medical implications of their venom proteomic profiles analyzed through the strategy of snake venomics".Journal of Proteomics.105:323–39.doi:10.1016/j.jprot.2014.02.020.PMID24576642.
  26. ^Hargreaves, Adam D.; Swain, Martin T.; Hegarty, Matthew J.; Logan, Darren W.; Mulley, John F. (August 2014)."Restriction and Recruitment—Gene Duplication and the Origin and Evolution of Snake Venom Toxins".Genome Biology and Evolution.6(8): 2088–2095.doi:10.1093/gbe/evu166.ISSN1759-6653.PMC4231632.PMID25079342.
  27. ^Lynch VJ (January 2007)."Inventing an arsenal: adaptive evolution and neofunctionalization of snake venom phospholipase A2 genes".BMC Evolutionary Biology.7(2): 2.doi:10.1186/1471-2148-7-2.PMC1783844.PMID17233905.
  28. ^Barlow A, Pook CE, Harrison RA, Wüster W (July 2009)."Coevolution of diet and prey-specific venom activity supports the role of selection in snake venom evolution".Proceedings. Biological Sciences.276(1666): 2443–2449.doi:10.1098/rspb.2009.0048.PMC2690460.PMID19364745.
  29. ^Pahari S, Bickford D, Fry BG, Kini RM (September 2007)."Expression pattern of three-finger toxin and phospholipase A2 genes in the venom glands of two sea snakes, Lapemis curtus and Acalyptophis peronii: comparison of evolution of these toxins in land snakes, sea kraits and sea snakes".BMC Evolutionary Biology.7:175.doi:10.1186/1471-2148-7-175.PMC2174459.PMID17900344.
  30. ^abBarlow A, Pook CE, Harrison RA, Wüster W (July 2009)."Coevolution of diet and prey-specific venom activity supports the role of selection in snake venom evolution".Proceedings: Biological Sciences.276(1666): 2443–9.doi:10.1098/rspb.2009.0048.JSTOR30244073.PMC2690460.PMID19364745.
  31. ^Jansa SA, Voss RS (22 June 2011)."Adaptive evolution of the venom-targeted vWF protein in opossums that eat pitvipers".PLOS ONE.6(6): e20997.Bibcode:2011PLoSO...620997J.doi:10.1371/journal.pone.0020997.PMC3120824.PMID21731638.
  32. ^Calvete JJ, Ghezellou P, Paiva O, Matainaho T, Ghassempour A, Goudarzi H, Kraus F, Sanz L, Williams DJ (July 2012). "Snake venomics of two poorly known Hydrophiinae: Comparative proteomics of the venoms of terrestrial Toxicocalamus longissimus and marine Hydrophis cyanocinctus".Journal of Proteomics.75(13): 4091–101.doi:10.1016/j.jprot.2012.05.026.PMID22643073.
  33. ^Li M, Fry BG, Kini RM (January 2005). "Eggs-only diet: its implications for the toxin profile changes and ecology of the marbled sea snake (Aipysurus eydouxii)".Journal of Molecular Evolution.60(1): 81–9.Bibcode:2005JMolE..60...81L.doi:10.1007/s00239-004-0138-0.PMID15696370.S2CID17572816.
  34. ^Mackessy SP (July 2010). "Evolutionary trends in venom composition in the western rattlesnakes (Crotalus viridis sensu lato): toxicity vs. tenderizers".Toxicon.55(8): 1463–74.doi:10.1016/j.toxicon.2010.02.028.PMID20227433.
  35. ^Saviola AJ, Chiszar D, Busch C, Mackessy SP (March 2013)."Molecular basis for prey relocation in viperid snakes".BMC Biology.11(1): 20.doi:10.1186/1741-7007-11-20.PMC3635877.PMID23452837.
  36. ^Youngman, Nicholas J; Llinas, Joshua; Haworth, Mark; Gillett, Amber; Jones, Lee; Walker, Andrew A; Fry, Bryan G (June 2022)."Untangling interactions between Bitis vipers and their prey using coagulotoxicity against diverse vertebrate plasmas".Toxicon.216:37–44.doi:10.1016/j.toxicon.2022.06.012.ISSN1879-3150.PMID35780972.S2CID250188352.
  37. ^Davies, Emma-Louise; Arbuckle, Kevin (December 2019)."Coevolution of Snake Venom Toxic Activities and Diet: Evidence that Ecological Generalism Favours Toxicological Diversity".Toxins.11(12): 711.doi:10.3390/toxins11120711.ISSN2072-6651.PMC6950196.PMID31817769.
  38. ^McCue MD (October 2007). "Prey envenomation does not improve digestive performance in western diamondback rattlesnakes (Crotalus atrox)".Journal of Experimental Zoology Part A.307(10): 568–77.doi:10.1002/jez.411.PMID17671964.
  39. ^Broeckhoven C, du Plessis A (August 2017)."Has snake fang evolution lost its bite? New insights from a structural mechanics viewpoint".Biology Letters.13(8): 20170293.doi:10.1098/rsbl.2017.0293.PMC5582107.PMID28768797.
  40. ^Cleuren SG, Hocking DP, Evans AR (June 2021)."Fang evolution in venomous snakes: Adaptation of 3D tooth shape to the biomechanical properties of their prey".Evolution; International Journal of Organic Evolution.75(6): 1377–1394.doi:10.1111/evo.14239.PMID33904594.S2CID233411378.
  41. ^Martin CJ, Lamb G (1907). "Snake-poison and Snake-bite". In Allbutt TC, Rolleston ND (eds.).A System of Medicine.London: MacMillan. pp. 783–821.
  42. ^McCleary RJ, Kini RM (February 2013). "Non-enzymatic proteins from snake venoms: a gold mine of pharmacological tools and drug leads".Toxicon.62:56–74.doi:10.1016/j.toxicon.2012.09.008.PMID23058997.
  43. ^Zouari-Kessentini R, Srairi-Abid N, Bazaa A, El Ayeb M, Luis J, Marrakchi N (2013)."Antitumoral potential of Tunisian snake venoms secreted phospholipases A2".BioMed Research International.2013:1–9.doi:10.1155/2013/391389.PMC3581298.PMID23509718.
  44. ^Vyas VK, Brahmbhatt K, Bhatt H, Parmar U (February 2013)."Therapeutic potential of snake venom in cancer therapy: current perspectives".Asian Pacific Journal of Tropical Biomedicine.3(2): 156–62.doi:10.1016/S2221-1691(13)60042-8.PMC3627178.PMID23593597.
  45. ^Jain D, Kumar S (2012)."Snake venom: a potent anticancer agent".Asian Pacific Journal of Cancer Prevention.13(10): 4855–60.doi:10.7314/apjcp.2012.13.10.4855.PMID23244070.
  46. ^de Oliveira Junior NG, e Silva Cardoso MH, Franco OL (December 2013)."Snake venoms: attractive antimicrobial proteinaceous compounds for therapeutic purposes".Cellular and Molecular Life Sciences.70(24): 4645–58.doi:10.1007/s00018-013-1345-x.PMC11113393.PMID23657358.S2CID15127065.
  47. ^Woolf CJ (January 2013). "Pain: morphine, metabolites, mambas, and mutations".The Lancet. Neurology.12(1): 18–20.doi:10.1016/S1474-4422(12)70287-9.PMID23237896.S2CID8697382.
  48. ^Osipov A, Utkin Y (December 2012). "Effects of snake venom polypeptides on central nervous system".Central Nervous System Agents in Medicinal Chemistry.12(4): 315–28.doi:10.2174/187152412803760618.PMID23270323.S2CID36274766.
  49. ^"Sterile tail abscess in Naja annulifera - self-envenomation case".Archived fromthe originalon 27 October 2004.Retrieved2 April2009.
  50. ^Drabeck D, Jansa S (2015). "Why the Honey Badger Doesn't Care: Independent Evolution of Resistance to Three Finger Toxins in the Nicotinic Acetylcholine Receptor".Toxicon.99:68–72.doi:10.1016/j.toxicon.2015.03.007.PMID25796346.
  51. ^Grasset E, Zoutendykanda A, Schaafsma A (1935). "Studies on the toxic and antigenic properties of Southern African snake venoms with specialreference to the polyvalency of South African antivenene".Trans. R. Soc. Trop. Med. Hygiene.28(6): 601–612.doi:10.1016/S0035-9203(35)90031-1.
  52. ^"Farewell to these famous Floridians".Florida Trend.19 December 2011.Retrieved2 April2012.
  53. ^Rosenberg C (21 June 2011)."Bill Haast dies at 100; snakes were the charm for south Florida celebrity".Los Angeles Times.Retrieved16 October2012.
  54. ^Schudel M (18 June 2011)."Bill Haast dies at 100: Florida snake man provided venom for snakebite serum".The Washington Post.Retrieved16 October2012.
  55. ^"Man makes deadly snakes bite him 160 times in hunt for human antidote | Americas | News | The Independent".Independent.co.uk.21 January 2016.Retrieved7 July2016.
  56. ^Hiremath VT, Taranath TC (February 2010)."Traditional Phytotherapy for Snake bites by Tribes of Chitradurga District, Karnataka, India".Ethnobotanical Leaflets.14(2): 120–125.
  57. ^Zethelius M, Balick MJ (March 1982)."Modern medicine and shamanistic ritual: a case of positive synergistic response in the treatment of a snakebite"(PDF).Journal of Ethnopharmacology.5(2): 181–5.doi:10.1016/0378-8741(82)90042-3.PMID7057657.
  58. ^"Treating Snake Bites".Ces.ncsu.edu.Retrieved16 October2012.
  59. ^"CDC - Venomous Snakes - NIOSH Workplace Safety and Health Topic".CDC.gov. 1 July 2016.Retrieved7 July2016.
  60. ^http://www.savagelabs.com/Products/CroFab/Home/crofab_frame.htmArchived3 March 2016 at theWayback MachineLink to PDF for full prescribing information, retrieved 11/12/12

Further reading

edit
edit
Wikimedia Commons has media related toSnake venom.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Snake_venom&oldid=1240444149"